Lerebours F - Search Results

1

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

Alberini JL, Lerebours F, Wartski M, Fourme E, Le Stanc E, Gontier E, Madar O, Cherel P, Pecking AP. Alberini JL, et al. Among authors: lerebours f. Cancer. 2009 Nov 1;115(21):5038-47. doi: 10.1002/cncr.24534. Cancer. 2009. PMID: 19645022 Free article. Clinical Trial.

2

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the French early access program.

Bello Roufai D, Gonçalves A, De La Motte Rouge T, Akla S, Blonz C, Grenier J, Gligorov J, Saghatchian M, Bailleux C, Simon H, Desmoulins I, Tharin Z, Renaud E, Bertho M, Benderra MA, Delaloge S, Robert L, Cottu P, Pierga JY, Loirat D, Bertucci A, Renouf B, Bidard FC, Lerebours F. Bello Roufai D, et al. Among authors: lerebours f. Oncogene. 2023 Apr;42(17):1417. doi: 10.1038/s41388-023-02615-8. Oncogene. 2023. PMID: 36922682 No abstract available.

3

[Rectal toxicity of Veganine suppositories: an unusual presentation].

Legallicier B, Parent B, Chamoun S, Duparc F, Lemoine F, Lerebours F, Colin R. Legallicier B, et al. Among authors: lerebours f. Gastroenterol Clin Biol. 1991;15(1):92-3. Gastroenterol Clin Biol. 1991. PMID: 2010078 French. No abstract available.

4

Evidence of chromosome regions and gene involvement in inflammatory breast cancer.

Lerebours F, Bertheau P, Bieche I, Driouch K, De The H, Hacene K, Espie M, Marty M, Lidereau R. Lerebours F, et al. Int J Cancer. 2002 Dec 20;102(6):618-22. doi: 10.1002/ijc.10729. Int J Cancer. 2002. PMID: 12448004 Free article.

5

Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I. Girault I, et al. Among authors: lerebours f. Clin Cancer Res. 2003 Apr;9(4):1259-66. Clin Cancer Res. 2003. PMID: 12684393

6

Two prognostic groups of inflammatory breast cancer have distinct genotypes.

Lerebours F, Bertheau P, Bieche I, Plassa LF, Champeme MH, Hacene K, Toulas C, Espie M, Marty M, Lidereau R. Lerebours F, et al. Clin Cancer Res. 2003 Sep 15;9(11):4184-9. Clin Cancer Res. 2003. PMID: 14519644

7

Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature.

Bièche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Bièche I, et al. Among authors: lerebours f. Clin Cancer Res. 2004 Oct 15;10(20):6789-95. doi: 10.1158/1078-0432.CCR-04-0306. Clin Cancer Res. 2004. PMID: 15501955

8

Update on inflammatory breast cancer.

Lerebours F, Bieche I, Lidereau R. Lerebours F, et al. Breast Cancer Res. 2005;7(2):52-8. doi: 10.1186/bcr997. Epub 2005 Jan 20. Breast Cancer Res. 2005. PMID: 15743511 Free PMC article. Review.

9

NF-kappa B genes have a major role in inflammatory breast cancer.

Lerebours F, Vacher S, Andrieu C, Espie M, Marty M, Lidereau R, Bieche I. Lerebours F, et al. BMC Cancer. 2008 Feb 4;8:41. doi: 10.1186/1471-2407-8-41. BMC Cancer. 2008. PMID: 18248671 Free PMC article.

10

Breast cancer with synchronous metastases: survival impact of exclusive locoregional radiotherapy.

Le Scodan R, Stevens D, Brain E, Floiras JL, Cohen-Solal C, De La Lande B, Tubiana-Hulin M, Yacoub S, Gutierrez M, Ali D, Gardner M, Moisson P, Villette S, Lerebours F, Munck JN, Labib A. Le Scodan R, et al. Among authors: lerebours f. J Clin Oncol. 2009 Mar 20;27(9):1375-81. doi: 10.1200/JCO.2008.19.5396. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204198

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page